National University Corporation OITA UNIVERSITY ("Oita University") and Hitachi High-Tech Corporation ("Hitachi High-Tech") today announced that we have started conducting research ("this research") ...

EpimAb Biotherapeutics, a clinical stage biotechnology company specializing in the development of bispecific antibodies and T ...

Data to be presented at IDWeek 2024 include: Presentation Title: Oral Sulopenem/probenecid for Uncomplicated Urinary Tract Infections (uUTI): Results from the REASSURE Trial Poster #: 1107 Presenter: ...

In the digital age, creating captivating content is essential for engaging audiences online. Learn how to design engaging ...

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that additional data from the ...

Exscientia researchers combined '565 with the BTK inhibitor zanubrutinib and observed deeper, more durable efficacy responses in xenograft models of B-cell malignancies, with long-lasting tumour ...

Full abstracts accepted as poster presentations will also be included in the special CTAD edition of the Journal of Prevention of Alzheimer’s Disease (JPAD), the official journal of the CTAD ...

Following the conference, the presentations presented at the 29 th Annual Congress of the WMS will be available on the Investors page of PepGen’s website under Scientific Publications.

INOVIO (NASDAQ: INO) is set to highlight its latest research in immunotherapy at several prestigious scientific conferences ...

Celyad Oncology (Euronext: CYAD) (the "Company"), today announces two poster presentations at the 39th Annual Meeting of the ...